Raffles Medical Group Ltd
RAFLF
$0.8073
$0.05737.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 577.00M | 566.52M | 562.59M | 542.43M | 520.67M |
| Total Other Revenue | 638.90K | 638.90K | 638.90K | 735.90K | 829.40K |
| Total Revenue | 577.64M | 567.16M | 563.23M | 543.16M | 521.50M |
| Cost of Revenue | 314.46M | 310.17M | 309.45M | 300.59M | 290.86M |
| Gross Profit | 263.19M | 256.99M | 253.78M | 242.57M | 230.63M |
| SG&A Expenses | 132.72M | 129.11M | 127.04M | 122.75M | 118.09M |
| Depreciation & Amortization | 33.24M | 32.12M | 31.36M | 29.78M | 28.11M |
| Other Operating Expenses | 32.75M | 32.04M | 31.69M | 31.08M | 30.38M |
| Total Operating Expenses | 513.16M | 503.44M | 499.54M | 484.20M | 467.45M |
| Operating Income | 64.48M | 63.72M | 63.69M | 58.96M | 54.05M |
| Income Before Tax | 66.03M | 65.17M | 65.08M | 63.95M | 62.63M |
| Income Tax Expenses | 17.85M | 18.06M | 18.47M | 17.73M | 16.93M |
| Earnings from Continuing Operations | 48.18 | 47.12 | 46.61 | 46.22 | 45.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -80.30K | -50.20K | -26.00K | -257.30K | -489.60K |
| Net Income | 48.10M | 47.06M | 46.59M | 45.96M | 45.21M |
| EBIT | 64.48M | 63.72M | 63.69M | 58.96M | 54.05M |
| EBITDA | 88.67M | 87.28M | 86.97M | 80.11M | 73.03M |
| EPS Basic | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| EPS Diluted | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 7.42B | 7.43B | 7.43B | 7.43B | 7.44B |
| Average Diluted Shares Outstanding | 7.43B | 7.46B | 7.49B | 7.50B | 7.51B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 72.69% | 71.45% | 71.04% | 72.00% | 73.21% |